Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma

BACKGROUND Few large, prospective, randomized studies have investigated the value and optimal application of neoadjuvant chemoradiotherapy followed by surgery (trimodality therapy) or definitive concurrent chemoradiotherapy (CCRT) for patients with thoracic esophageal squamous cell carcinoma (TESCC)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2017-10, Vol.123 (20), p.3904-3915
Hauptverfasser:	Lin, Wei‐Cheng, Ding, Yi‐Fang, Hsu, Han‐Lin, Chang, Jer‐Hwa, Yuan, Kevin Sheng‐Po, Wu, Alexander T. H., Chow, Jyh‐Ming, Chang, Chia‐Lun, Chen, Shee‐Uan, Wu, Szu‐Yuan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Alcohol Drinking - epidemiology Alcohols Cancer Carcinoma, Squamous Cell - mortality Carcinoma, Squamous Cell - pathology Carcinoma, Squamous Cell - therapy Chemoradiotherapy Chemotherapy Cigarette smoking Combined Modality Therapy concurrent chemoradiotherapy (CCRT) Confidence intervals Data processing Databases, Factual Digestive System Surgical Procedures Esophageal cancer Esophageal Neoplasms - mortality Esophageal Neoplasms - pathology Esophageal Neoplasms - therapy Esophageal Squamous Cell Carcinoma Esophagus Esophagus - surgery Female Humans Kaplan-Meier Estimate Male Medical prognosis Metastases Middle Aged Mortality Multivariate Analysis Neoadjuvant Therapy Neoplasm Staging Oncology Patients Prognosis Proportional Hazards Models Radiation therapy Registries Regression analysis Smoking Smoking - epidemiology Squamous cell carcinoma Studies Surgery surgery alone Survival Taiwan Therapy thoracic esophageal cancer Thorax trimodality therapy Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!